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Autophagy initiation is strictly dependent on phosphatidylinositol 3-phosphate (PI3P) synthesis.
PI3P production is under tight control of PI3Kinase, hVps34, in complex with Beclin-1. Mammalian
cells express several PI3P phosphatases that belong to the myotubularin family. Even though some
of them have been linked to serious human diseases, their cellular function is largely unknown. Two
recent studies indicate that PI3Pmetabolism involved in autophagy initiation is further regulated by
the PI3P phosphatases Jumpy and MTMR3. Additional pools of PI3P, upstream of mTOR and on the
endocytic pathway, may modulate autophagy indirectly, suggesting that other PI3P phosphatases
might be involved in this process. This review sums up our knowledge on PI3P phosphatases and
discusses the recent progress on their role in autophagy.
Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
PI3P synthesis has long been recognized as one of the key
events in the initiation of the autophagic process [1]. The phos-
phorylation of phosphatidylinositol is catalyzed by the well
known, type III phosphatidylinositol 3-kinase, hVps34, in complex
with the autophagy proteins, Beclin-1 (Atg6) and Atg14 [2–4]
(Fig. 1). This highly regulated complex (see chapter in this issue),
conserved from yeast to humans, allows spatio-temporal control
of autophagy initiation [5]. Besides, and in contrast, to this proxi-
mal action at the early stage of autophagy, PI3P may also regulate
autophagy upstream of mTOR, a negative regulator autophagy.
Amino-acids have been shown to stimulate mTOR activity via
hVps34 activation [6–7], therefore, this pool of PI3P could poten-
tially inhibit autophagy, even though at the moment, evidence is
lacking to support this model. Finally, PI3P plays a major role in
the endocytic pathway where it promotes fusion of endosomes
and receptor degradation [8]. Since autophagic and endocytic path-
ways merge, it is likely that this third pool of PI3P modulates either
directly or indirectly the last stages of autophagy [9,10].
Although, the synthesis of PI3P and its regulation have been
well studied, how PI3P is turned-over and how autophagy is
turned-off once PI3P is produced, remained to be elucidated. Thelf of the Federation of European Bi
olecular Genetics and Micro-
enter, 915 Camino de Salud,
6029.
).PI3P phosphatases were one of the likely candidates as it is known
that the phosphoinositide, PI3,4,5P3 and its signaling can be down-
regulated by PI3,4,5P3 phosphatase, PTEN. In this review we will
summarize brieﬂy the structure and functions of PI3P phospha-
tases (for reviews see, [11–13]) culminating in a discussion of
the recently developing role of PI3P phosphatases in autophagy.2. Structure and expression of PI3P phosphatases
In mammalian cells PI3P phosphatases belong to the myotubul-
arin family [11–13]. This subgroup of phosphatases contains 15
members in humans of which all have a characteristic phosphatase
domain with a CX5R motif. Only nine of them, MTM1 (also called
myotubularin), MTMR1, MTMR2, MTMR3, MTMR4, MTMR6,
MTMR7, MTMR8 and Jumpy (also known as MTMR14), possess
an active phosphatase domain, that speciﬁcally dephosphorylates
PI3P and phosphatidylinositol (3,5)-bisphosphate (PI3,5P2) at posi-
tion 3 on inositol ring. However, MTMR7 seems to have preference
for inositol (1,3)-bisphosphate as a soluble substrate [14]. The six
remaining myotubularins are inactive pseudophosphatases due
to a substitution of Cys and Arg residues in their catalytic site. Be-
sides the catalytic domain, all myotubularins, with the exception of
MTMR14, contain two other protein domains, PH-GRAM (Pleck-
strin Homology-Glucosyl transferases, Rab-like GTPase activators
and myotubularins) and coiled-coil, that are believed to be impor-
tant for lipid–protein or protein–protein interactions. Subgroups of
myotubularins present additional domains such as PH and FYVEochemical Societies.
Fig. 1. Myotubularin family: activity and different members with their domains. hVps34 catalyzes phosphatidylinositol (PI) phosphorylation at position 3 on inositol ring to
form phosphatidylinositol 3-phosphate (PI3P). PI3P can be further phosphorylated by PIKfyve to generate PI3,5,P2. Myotubularins remove 3-phosphate on PI3P and PI3,5P2
resulting in generation of PI and PI5P, respectively. Nine active and six inactive phosphatases are present in humans. See text for domain description.
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likely to mediate protein–protein interaction and DENN in inactive
myotubularins MTMR5 and MTMR13 (Fig. 1) [11,12]. Myotubula-
rins are ubiquitously expressed, however, they can be enriched in
certain tissues. For instance, MTM1 and Jumpy are highly ex-
pressed in skeletal muscles whereas MTMR2 is abundant in neu-
rons and Schwann cells [15–19].
Saccharomyces. cerevisiae genome encodes only one myotubula-
rin, Ymr1p. However, yeast expresses two additional unrelated
phosphatases, members of the synaptojanin-like family, Sjl2p and
Sjl3p that account also for PI3P dephosphorylation [20]. Only
ymr1D sjl3D and ymr1D sjl3D double mutants show a signiﬁcant
increase in PI3P level, suggesting that these phosphatases may
have redundant function in yeast [20].
3. PI3P phosphatases and diseases
Four of the ﬁfteen PI3P phosphatases present in mammals have
been linked to serious human diseases. MTM1 defects cause X-
linked myotubular myopathy (XLMTM) also known as centronu-
clear myopathy, a severe congenital disorder affecting the physiol-
ogy of skeletal muscle ﬁbers and characterized by centrally
localized nuclei and hypotonia [12,13]. More than two hundred
different mutations, truncations and missenses, in MTM1 have
been reported in XLMTM patients that result in loss or decrease
of MTM1 level [21]. A severe case of centronuclear myopathy
was observed in one patient with an inactive MTM1 suggesting
that XLMTM is likely due to defect in PI3P metabolism [21].
MTM1 knockout mice studies indicate that myotubularin is essen-
tial for muscle growth and maintenance but not for myogenesis
[22]. Histopathological analyses of MTM1-deﬁcient mice reveal
skeletal hypotrophic myoﬁbers with numerous vacuoles [22].
However, ultrastructural analyses show that these vacuoles do
not seem to contain cellular debris [22].Recently, another gene encoding for a PI3P phosphatase, jumpy,
has been identiﬁed as mutated in some patients with centronucle-
ar myopathy [15]. The mutations lead to a reduced or total loss of
phosphatase activity and they are likely the basis for the disease as
observed for MTM1 [15]. Indeed, a recent study reports that
MTMR14/ mice display muscle weakness and fatigue similar to
patients with centronuclear myopathy [16].
MTMR2 and MTMR13 have been found mutated in two forms of
Charcot–Marie–Tooth (CMT) Type 4B disease, an autosomal reces-
sive disorder of the peripheral nervous system characterized by
nerve demyelination and myelin outfoldings [13,21]. CMT type
4B1 is caused by missense or deletion mutations in MTMR2 gene
that result in MTMR2 loss of function. In addition to CMT4B1,
one patient manifests azoospermia suggesting that MTMR2 also
plays a role in testis. MTMR2-deﬁcient mice develop CMT4B1-like
neuropathy and azoospermia [21]. Interesting, inactive myotubul-
arin MTMR5, which interacts with MTMR2, has been shown to be
essential for spermatogenesis in mice [13]. Cell type-speciﬁc gene
knockout indicates that loss of MTMR2 in Schwann cells but not in
neurons leads to CMT4B1-like neuropathy. CMT type 4B2 is due to
mutations in MTMR13 gene which encodes a pseudophosphatase
[12,13]. MTMR13-deﬁcient mice manifest myelin outfoldings in
peripheral nerves very similar to ones found in CMT4B2 [13]. It
has been suggested that MTMR2 might form two complexes, one
with MTMR5, in Sertoli or germ cells, involved in spermatogenesis
and a second one with MTMR13, in Schwann cells, important in
myelin homeostasis [13].
4. Regulation and cellular functions of PI3P phosphatases
One important feature of myotubularins is their ability to form
homo- and heterodimers [23] (Table 1). These interactions often
lead to an enhancement of phosphatase activity or to regulation
of myotubularin intracellular localization. For instance, MTMR9,
Table 1
Protein interacting partners of active PI3P phosphatases.
Myotubularins Interacting partners Effects or functions References
MTM1 Myotubularins: 1, R10, R12 MTM1 activity increase with MTM1 oligomerization
MTM1 redistribution with MTMR12
[23,27,53]
p150 (hVps34) Unknown [35]
MTMR1 Unknown – –
MTMR2 Myotubularins: R2, R5, R10, R12, R13 MTMR2 activity increase with MTMR13
MTMR2 redistribution with MTMR5
[23,25,26,53,54]
p150 (hVps34) MTMR2 activity decrease
Indirect PI3P inhibition
[33]
Neuroﬁlament light chain,
Disk large 1 Dlg1/SAP97
Myelin outfoldings regulation with Dlg1 [38,55,56]
Non-receptor protein tyrosine kinase c-Src Possibly cell adhesion regulation [57]
MTMR3 Myotubularins: R3, R4 MTMR3 redistribution with MTMR4 [23]
MTMR4 Myotubularins: R3, R4 MTMR4 redistribution with MTMR3 [23]
Ubiquitin ligase Nedd4 Unknown [58]
MTMR6 Myotubularins: R9 MTMR6 activity increase
MTMR6 stability increase
[23,24]
Ca2+-activated K+ channel (K(Ca)3.1) Indirect K(Ca)3.1 inhibition [42]
MTMR7 Myotubularins: R9 MTMR7 activity increase [14,23]
MTMR8 Myotubularins: R8, R9 Unknown [23]
MTMR14 Unknown – –
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ing in a signiﬁcant increase of their activities [14,24] whereas
MTMR13 binds and activates MTMR2 [25]. Myotubularin coiled-
coil domains play a major role in oligomer formation [14,26]. Gen-
erally, these interactions take place between active and inactive
myotubularins [23], however, it is interesting to note that MTMR3
and MTMR4, two active phosphatases also form a heterodimer,
which has been postulated to play a role in their redistribution
within cells [23]. Importantly, phosphatase activity does not seem
to be required for myotubularin interactions [23,27]. Several other
myotubularin interacting proteins have been identiﬁed and they
are summarized in Table 1.
In addition to being regulated by other myotubularins, MTM1,
MTMR3 and MTMR6 have been shown to be activated by phospha-
tidylinositol 5-phosphate (PI5P), the product of PI3,5P2 dephospho-
rylation [27]. PI5P binds to PH-GRAM, a domain important for
MTM1 and MTMR3 phosphatase activities, and for MTMR2,
MTMR3 and MTMR6 association to intracellular membranes [27–
30]. PI5P is a speciﬁc allosteric activator of MTM1 that promotes
oligomerization of MTM1 into a heptamer [27].
For the most part, the biological functions of myotubularins are
poorly understood. When overexpressed most myotubularins pro-
mote a decrease in PI3P levels on endosomal compartments [23].
Exogenously expressed myotubularins are found in cytosol and
on intracellular structures that display different partners depend-
ing on the myotubularin investigated, suggesting that each myotu-
bularin is targeted to a speciﬁc intracellular compartment where it
dephosphorylates a deﬁnite pool of PI3P [23]. A recent siRNA
screen identiﬁed several myotubularins, MTMR1, MTMR6, MTMR7,
MTMR8 and MTMR12, as being important for cellular survival, yet,
the molecular mechanisms behind this effect remain to be clariﬁed
[31]. Since both are associated with debilitating human illnesses,
MTM1 and MTMR2 have been the most studied. MTM1 is present
on rufﬂes at the plasma membrane, on early endosomes and par-
tially on late endosomes where they regulate intracellular trafﬁck-
ing of Glut-4 and EGF receptor, respectively [32–35]. In muscle
ﬁbers lacking MTM1, the structure of T-tubules, invaginations orig-
inating from the plasma membrane, is impaired, supporting the
idea of MTM1 being involved in membrane trafﬁc [36–37]. MTMR2
localizes on Rab7 positive compartment and similar to MTM1 itsdepletion results in reduction of EGFR degradation [33]. In Schw-
ann cells MTMR2 is believed to play an important role in mem-
brane homeostasis at the plasma membrane during the process
of myelination [38]. Interestingly, MTMR2 binds to type III PI3K
regulatory subunit, hVps15 (p150), which results in inhibition of
phosphatase activity and in diminution of hVps34–Rab7 interac-
tion important for PI3P synthesis [33] (Table 1). A similar binding
was also observed between MTM1 and hVps15 [35]. Finally, a re-
cent study reports that in muscle ﬁbers, MTMR14 regulates Ca2+
homeostasis by dephosphorylating PI3,5P2, an activator of Ca2+ re-
lease channel ryanodine receptor 1 [16].
5. PI3P phosphatases and autophagy
The majority of PI3P phosphatase functions described so far
take place along the endocytic pathway. Given that PI3P plays a
central role in autophagy, we wondered whether PI3P phospha-
tase(s) were also involved in regulating this pathway. A recent
siRNA-based screen identiﬁed three PI3P phosphatases, Jumpy,
MTMR6 and MTMR7, that affect level of autophagic marker
LC3-II [39].
Jumpy-depleted mammalian cells show an increase in number
of autophagic vacuoles in nutrient-rich and starvation conditions
as well as an upregulation of long-lived protein proteolysis [39].
In contrast cells overexpressing Jumpy but not MTM1 or MTMR2,
fail to degrade autophagic substrate p62 leading to accumulation
of protein aggregates [39]. Jumpy colocalizes with LC3 positive
compartments in particular with isolation membranes marked
with Atg12 and Atg16 indicating that this phosphatase acts di-
rectly, and at an early stage of autophagic process [39]. Impor-
tantly, Jumpy regulates Atg9 intracellular distribution, a PI3P-
dependent event important for initiating autophagy [39–41]. In
yeast, Atg9 retrieval from autophagosomes requires the PI3P-bind-
ing protein Atg18 [41]. Interestingly, Jumpy depletion in mamma-
lian cells increases WIPI-1 (Atg18 ortholog) on membranes [39]
suggesting that Jumpy dephosphorylates a pool of PI3P involved
in WIPI-1 binding and Atg9 retrieval. In the future it would be
important to elucidate the molecular mechanisms involved in Jum-
py targeting to autophagic vacuoles and its regulation. In addition
to increasing autophagy initiation, Jumpy depletion also promotes
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moment is unclear, whether this later effect is coupled to the initi-
ation event or whether Jumpy acts at two different stages of the
pathway. Inactive Jumpy variant, R336Q, found in one patient with
centronuclear myopathy, is unable to inhibit autophagy suggesting
that deregulation of autophagic pathway might be an important
contributing factor to the disease [39].
Inmacrophages, MTMR6 andMTMR7 knockdown increase LC3-II
level suggesting that additional phosphatases besides Jumpymay be
important in regulating autophagy, however their mechanism of
action remains to be investigated [39]. MTMR6 is known to prevent
activation of Ca2+-activated K+ channel, KCa3.1, which results in de-
creased Ca2+ inﬂux during T-cell activation [42]. Even though the
role of Ca2+ in autophagy is still controversial [43–45], it is possible
that MTMR6 modulates indirectly the autophagic response through
change in Ca2+ homeostasis (Fig. 2).
Walker et al. 2001 reported that an inactive form ofMTMR3,mu-
tant C413S, is present inside compartment resembling autophago-
somes in Hela cells [46]. More recently, MTMR3 was reported to
regulate constitutive autophagy initiation and autophagosome size
in epithelial cells [47]. However, MTMR3 knockdown does not af-
fect steady-state level of LC3-II in macrophages [39]. One possible
explanation for this apparent discrepancy is that MTMR3 and Jum-
py might play a redundant role during constitutive autophagy
depending on cell types and levels of expression. Yet, given that
Jumpy lacks most of MTMR3 domains, theirs modes of regulation
and recruitment are likely to be different.
PI3P is known to be a substrate for PIP5-kinase, Fab1 (also
named PIKfyve), an enzyme that generates phosphoinositide
PI3,5P2 (Fig. 1). Although PI3,5P2 does not appear to be importantFig. 2. Intracellular PI3P pools and PI3P phosphatases in autophagy regulation.
MTMR14 and MTMR3 inhibit autophagy by dephosphorylating PI3P involved in
autophagosome formation. MTMR6 and MTMR7 depletions increase LC3-II via
unknown mechanisms. Since MTMR6 regulates KCa3.1, we propose that MTMR6
might modulate autophagy by acting on Ca2+ inﬂux. We speculate that some PI3P
phosphatases might regulate autophagy by dephosphorylating pools of PI3P and/or
PI3,5P2 involved in Akt and mTOR activation (a and b), autolysosome formation/
membrane recycling (c) and autophagosome transport (d) (see text and [52]). AP:
autophagosome; AL: autolysosome. a.a.: amino-acids. In red: PI3P phosphatases
inhibiting autophagy. IM: isolation membrane; In bold: PI3P phosphatases whose
knockdown affect LC3-II level. Question marks indicate that the role of these
pathways in regulating autophagy is speculative and remains to be investigated.for autophagy in yeast, several studies indicate that PI3,5P2 plays
a key role in maturation of autophagosomes in mammals and ﬂies
[9,10,48]. Mice deﬁcient for Fig4 and Vac14, two regulatory pro-
teins required for PI3,5P2 synthesis, accumulate p62 in Lamp-2 po-
sitive compartments in neurons and astrocytes [48]. Chemical
inhibition of PIKfyve activity was shown to block LC3-II turn-over,
and in drosophila, with impaired Fab1 function, an accumulation of
autolysosomes was observed [9,10]. Since myotubularins are also
efﬁcient PI3,5P2 phosphatases, one can speculate that they might
also be involved in late stages of autophagy.
Dephosphorylation of PI3,5P2 by myotubularins gives rise to
PI5P (Fig. 1). In particular, cells overexpressing MTM1 show an in-
crease in the amount of PI5P which was not observed in cells
expressing an inactive mutant D278A [49]. This rare phospholipid,
PI5P, has been found to activate the Akt pathway, though its mech-
anism of action remains elusive [50]. It is important to note that
MTMR2 overexpression also leads to sustained Akt activation
[51]. Thus, myotubularins may potentially activate mTOR via gen-
eration of PI5P and consequently block autophagy (Fig. 2). On the
other hand, as we mentioned in the introduction, amino-acid-med-
iated PI3P synthesis induces mTOR activation [6,7]. Therefore, if
any myotubularin acts on this PI3P pool, it might affect mTOR
activity and therefore autophagic response (Fig. 2). Anyhow, it
would be of interest to investigate whether myotubularins play a
role in regulating Akt/mTOR pathway and hence autophagy.
6. Conclusions and perspectives
The discovery of the PI3P phosphatases, Jumpy and more re-
cently, MTMR3, as regulators of autophagy, shed some light on
an unappreciated regulatory mechanism of the autophagic process.
The initiation of autophagy is not only controlled by hVps34/Be-
clin-1-mediated synthesis of PI3P but also by its turn-over via ac-
tion of speciﬁc phosphatases. These ﬁndings add Jumpy and
MTMR3 to the list of potential therapeutic targets that could be
used to modulate autophagy in the context of human diseases.
The recent work on PI3P phosphatases and autophagy also indicate
that other myotubularins could be implicated in this process. Elu-
cidating their biological functions will undoubtedly improve our
understanding of autophagy pathway and its regulation.Acknowledgements
This work was supported by grants AI45148 from the National
Institutes of Health to VD. This project was supported in part by
the Dedicated Health Research Funds from the University of New
Mexico School of Medicine to IV.References
[1] Petiot, A., Ogier-Denis, E., Blommaart, E.F., Meijer, A.J. and Codogno, P. (2000)
Distinct classes of phosphatidylinositol 30-kinases are involved in signaling
pathways that control macroautophagy in HT-29 cells. J. Biol. Chem. 275, 992–
998.
[2] Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X.H., Mizushima, N., Packer, M.,
Schneider, M.D. and Levine, B. (2005) Bcl-2 antiapoptotic proteins inhibit
Beclin 1-dependent autophagy. Cell 122, 927–939.
[3] Tassa, A., Roux, M.P., Attaix, D. and Bechet, D.M. (2003) Class III
phosphoinositide 3-kinase–Beclin1 complex mediates the amino acid-
dependent regulation of autophagy in C2C12 myotubes. Biochem. J. 376,
577–586.
[4] Itakura, E., Kishi, C., Inoue, K. and Mizushima, N. (2008) Beclin 1 forms two
distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and
UVRAG. Mol. Biol. Cell 19, 5360–5372.
[5] Simonsen, A. and Tooze, S.A. (2009) Coordination of membrane events during
autophagy by multiple class III PI3–kinase complexes. J. Cell Biol. 186, 773–
782.
[6] Nobukuni, T., Joaquin, M., Roccio, M., Dann, S.G., Kim, S.Y., Gulati, P., Byﬁeld,
M.P., Backer, J.M., Natt, F., Bos, J.L., et al. (2005) Amino acids mediate mTOR/
I. Vergne, V. Deretic / FEBS Letters 584 (2010) 1313–1318 1317raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase.
Proc. Natl. Acad. Sci. USA 102, 14238–14243.
[7] Byﬁeld, M.P., Murray, J.T. and Backer, J.M. (2005) HVps34 is a nutrient-
regulated lipid kinase required for activation of p70 S6 kinase. J. Biol. Chem.
280, 33076–33082.
[8] Lindmo, K. and Stenmark, H. (2006) Regulation of membrane trafﬁc by
phosphoinositide 3-kinases. J. Cell Sci. 119, 605–614.
[9] de Lartigue, J., Polson, H., Feldman, M., Shokat, K., Tooze, S.A., Urbe, S. and
Clague, M.J. (2009) PIKfyve regulation of endosome-linked pathways. Trafﬁc
10, 883–893.
[10] Rusten, T.E., Vaccari, T., Lindmo, K., Rodahl, L.M., Nezis, I.P., Sem-Jacobsen, C.,
Wendler, F., Vincent, J.P., Brech, A., Bilder, D., et al. (2007) ESCRTs and Fab1
regulate distinct steps of autophagy. Curr. Biol. 17, 1817–1825.
[11] Clague, M.J. and Lorenzo, O. (2005) The myotubularin family of lipid
phosphatases. Trafﬁc 6, 1063–1069.
[12] Laporte, J., Bedez, F., Bolino, A. and Mandel, J.L. (2003) Myotubularins, a large
disease-associated family of cooperating catalytically active and inactive
phosphoinositides phosphatases. Hum. Mol. Genet. 12, R285–292 (Spec No. 2).
[13] Robinson, F.L. and Dixon, J.E. (2006) Myotubularin phosphatases: policing 3-
phosphoinositides. Trends Cell Biol. 16, 403–412.
[14] Mochizuki, Y. and Majerus, P.W. (2003) Characterization of myotubularin-
related protein 7 and its binding partner, myotubularin-related protein 9.
Proc. Natl. Acad. Sci. USA 100, 9768–9773.
[15] Tosch, V., Rohde, H.M., Tronchere, H., Zanoteli, E., Monroy, N., Kretz, C.,
Dondaine, N., Payrastre, B., Mandel, J.L. and Laporte, J. (2006) A novel PtdIns3P
and PtdIns(3, 5)P2 phosphatase with an inactivating variant in centronuclear
myopathy. Hum. Mol. Genet. 15, 3098–3106.
[16] Shen, J., Yu, W.M., Brotto, M., Scherman, J.A., Guo, C., Stoddard, C., Nosek, T.M.,
Valdivia, H.H. and Qu, C.K. (2009) Deﬁciency of MIP/MTMR14 phosphatase
induces a muscle disorder by disrupting Ca(2+) homeostasis. Nat. Cell Biol. 11,
769–776.
[17] Laporte, J., Blondeau, F., Buj-Bello, A., Tentler, D., Kretz, C., Dahl, N. and Mandel,
J.L. (1998) Characterization of the myotubularin dual speciﬁcity phosphatase
gene family from yeast to human. Hum. Mol. Genet. 7, 1703–1712.
[18] Berger, P., Bonneick, S., Willi, S., Wymann, M. and Suter, U. (2002) Loss
of phosphatase activity in myotubularin-related protein 2 is associated
with Charcot–Marie–Tooth disease type 4B1. Hum. Mol. Genet. 11, 1569–
1579.
[19] Bolino, A., Marigo, V., Ferrera, F., Loader, J., Romio, L., Leoni, A., Di Duca, M.,
Cinti, R., Cecchi, C., Feltri, M.L., et al. (2002) Molecular characterization and
expression analysis of Mtmr2, mouse homologue of MTMR2, the
myotubularin-related 2 gene, mutated in CMT4B. Gene 283, 17–26.
[20] Parrish, W.R., Stefan, C.J. and Emr, S.D. (2004) Essential role for the
myotubularin-related phosphatase Ymr1p and the synaptojanin-like
phosphatases Sjl2p and Sjl3p in regulation of phosphatidylinositol 3-
phosphate in yeast. Mol. Biol. Cell 15, 3567–3579.
[21] Nicot, A.S. and Laporte, J. (2008) Endosomal phosphoinositides and human
diseases. Trafﬁc 9, 1240–1249.
[22] Buj-Bello, A., Laugel, V., Messaddeq, N., Zahreddine, H., Laporte, J., Pellissier, J.F.
and Mandel, J.L. (2002) The lipid phosphatase myotubularin is essential for
skeletal muscle maintenance but not for myogenesis in mice. Proc. Natl. Acad.
Sci. USA 99, 15060–15065.
[23] Lorenzo, O., Urbe, S. and Clague, M.J. (2006) Systematic analysis of
myotubularins: heteromeric interactions, subcellular localisation and
endosome related functions. J. Cell Sci. 119, 2953–2959.
[24] Zou, J., Chang, S.C., Marjanovic, J. and Majerus, P.W. (2009) MTMR9 increases
MTMR6 enzyme activity, stability, and role in apoptosis. J. Biol. Chem. 284,
2064–2071.
[25] Berger, P., Berger, I., Schafﬁtzel, C., Tersar, K., Volkmer, B. and Suter, U. (2006)
Multi-level regulation of myotubularin-related protein-2 phosphatase activity
by myotubularin-related protein-13/set-binding factor-2. Hum. Mol. Genet.
15, 569–579.
[26] Kim, S.A., Vacratsis, P.O., Firestein, R., Cleary, M.L. and Dixon, J.E. (2003)
Regulation of myotubularin-related (MTMR)2 phosphatidylinositol
phosphatase by MTMR5, a catalytically inactive phosphatase. Proc. Natl.
Acad. Sci. USA 100, 4492–4497.
[27] Schaletzky, J., Dove, S.K., Short, B., Lorenzo, O., Clague, M.J. and Barr, F.A. (2003)
Phosphatidylinositol-5-phosphate activation and conserved substrate
speciﬁcity of the myotubularin phosphatidylinositol 3-phosphatases. Curr.
Biol. 13, 504–509.
[28] Berger, P., Schafﬁtzel, C., Berger, I., Ban, N. and Suter, U. (2003) Membrane
association of myotubularin-related protein 2 is mediated by a pleckstrin
homology-GRAM domain and a coiled-coil dimerization module. Proc. Natl.
Acad. Sci. USA 100, 12177–12182.
[29] Lorenzo, O., Urbe, S. and Clague, M.J. (2005) Analysis of phosphoinositide
binding domain properties within the myotubularin-related protein MTMR3.
J. Cell Sci. 118, 2005–2012.
[30] Choudhury, P., Srivastava, S., Li, Z., Ko, K., Albaqumi, M., Narayan, K., Coetzee,
W.A., Lemmon, M.A. and Skolnik, E.Y. (2006) Speciﬁcity of the myotubularin
family of phosphatidylinositol-3-phosphatase is determined by the PH/GRAM
domain. J. Biol. Chem. 281, 31762–31769.
[31] MacKeigan, J.P., Murphy, L.O. and Blenis, J. (2005) Sensitized RNAi screen of
human kinases and phosphatases identiﬁes new regulators of apoptosis and
chemoresistance. Nat. Cell Biol. 7, 591–600.
[32] Laporte, J., Blondeau, F., Gansmuller, A., Lutz, Y., Vonesch, J.L. and Mandel, J.L.
(2002) The PtdIns3P phosphatase myotubularin is a cytoplasmic protein thatalso localizes to Rac1-inducible plasma membrane rufﬂes. J. Cell Sci. 115,
3105–3117.
[33] Cao, C., Backer, J.M., Laporte, J., Bedrick, E.J. and Wandinger-Ness, A.
(2008) Sequential actions of myotubularin lipid phosphatases regulate
endosomal PI(3)P and growth factor receptor trafﬁcking. Mol. Biol. Cell
19, 3334–3346.
[34] Chaussade, C., Pirola, L., Bonnafous, S., Blondeau, F., Brenz-Verca, S., Tronchere,
H., Portis, F., Rusconi, S., Payrastre, B., Laporte, J., et al. (2003) Expression of
myotubularin by an adenoviral vector demonstrates its function as a
phosphatidylinositol 3-phosphate [PtdIns(3)P] phosphatase in muscle cell
lines: involvement of PtdIns(3)P in insulin-stimulated glucose transport. Mol.
Endocrinol. 17, 2448–2460.
[35] Cao, C., Laporte, J., Backer, J.M., Wandinger-Ness, A. and Stein, M.P. (2007)
Myotubularin lipid phosphatase binds the hVPS15/hVPS34 lipid kinase
complex on endosomes. Trafﬁc 8, 1052–1067.
[36] Dowling, J.J., Vreede, A.P., Low, S.E., Gibbs, E.M., Kuwada, J.Y., Bonnemann, C.G.
and Feldman, E.L. (2009) Loss of myotubularin function results in T-tubule
disorganization in zebraﬁsh and human myotubular myopathy. PLoS Genet. 5,
e1000372.
[37] Al-Qusairi, L., Weiss, N., Toussaint, A., Berbey, C., Messaddeq, N., Kretz, C.,
Sanoudou, D., Beggs, A.H., Allard, B., Mandel, J.L., et al. (2009) T-tubule
disorganization and defective excitation–contraction coupling in muscle ﬁbers
lacking myotubularin lipid phosphatase. Proc. Natl. Acad. Sci. USA 106,
18763–18768.
[38] Bolis, A., Coviello, S., Visigalli, I., Taveggia, C., Bachi, A., Chishti, A.H., Hanada, T.,
Quattrini, A., Previtali, S.C., Bifﬁ, A., et al. (2009) Dlg1, Sec8, and Mtmr2
regulate membrane homeostasis in Schwann cell myelination. J. Neurosci. 29,
8858–8870.
[39] Vergne, I., Roberts, E., Elmaoued, R.A., Tosch, V., Delgado, M.A., Proikas-
Cezanne, T., Laporte, J. and Deretic, V. (2009) Control of autophagy initiation
by phosphoinositide 3-phosphatase jumpy. EMBO J. 28, 2244–2258.
[40] Young, A.R., Chan, E.Y., Hu, X.W., Kochl, R., Crawshaw, S.G., High, S., Hailey,
D.W., Lippincott-Schwartz, J. and Tooze, S.A. (2006) Starvation and ULK1-
dependent cycling of mammalian Atg9 between the TGN and endosomes. J.
Cell Sci. 119, 3888–3900.
[41] Reggiori, F., Tucker, K.A., Stromhaug, P.E. and Klionsky, D.J. (2004) The Atg1–
Atg13 complex regulates Atg9 and Atg23 retrieval transport from the pre-
autophagosomal structure. Dev. Cell 6, 79–90.
[42] Srivastava, S., Li, Z., Lin, L., Liu, G., Ko, K., Coetzee, W.A. and Skolnik, E.Y. (2005)
The phosphatidylinositol 3-phosphate phosphatase myotubularin- related
protein 6 (MTMR6) is a negative regulator of the Ca2+-activated K+ channel
KCa3.1. Mol. Cell Biol. 25, 3630–3638.
[43] Kim, H.J., Soyombo, A.A., Tjon-Kon-Sang, S., So, I. and Muallem, S. (2009) The
Ca(2+) channel TRPML3 regulates membrane trafﬁcking and autophagy.
Trafﬁc 10, 1157–1167.
[44] Hoyer-Hansen, M., Bastholm, L., Szyniarowski, P., Campanella, M., Szabadkai,
G., Farkas, T., Bianchi, K., Fehrenbacher, N., Elling, F., Rizzuto, R., et al. (2007)
Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-
beta, and Bcl-2. Mol. Cell 25, 193–205.
[45] Gordon, P.B., Holen, I., Fosse, M., Rotnes, J.S. and Seglen, P.O. (1993)
Dependence of hepatocytic autophagy on intracellularly sequestered
calcium. J. Biol. Chem. 268, 26107–26112.
[46] Walker, D.M., Urbe, S., Dove, S.K., Tenza, D., Raposo, G. and Clague, M.J. (2001)
Characterization of MTMR3. an inositol lipid 3-phosphatase with novel
substrate speciﬁcity. Curr. Biol. 11, 1600–1605.
[47] Taguchi-Atarashi, N., Hamasaki, M., Matsunaga, K., Omori, H., Ktistakis, N.T.,
Yoshimori, T. and Noda, T. Modulation of local PtdIns3P levels by the PI
phosphatase MTMR3 regulates constitutive autophagy. Trafﬁc. [Epub ahead of
print].
[48] Ferguson, C.J., Lenk, G.M. and Meisler, M.H. (2009) Defective autophagy in
neurons and astrocytes from mice deﬁcient in PI(3, 5)P2. Hum. Mol. Genet. 18,
4868–4878.
[49] Tronchere, H., Laporte, J., Pendaries, C., Chaussade, C., Liaubet, L., Pirola, L.,
Mandel, J.L. and Payrastre, B. (2004) Production of phosphatidylinositol 5-
phosphate by the phosphoinositide 3-phosphatase myotubularin in
mammalian cells. J. Biol. Chem. 279, 7304–7312.
[50] Pendaries, C., Tronchere, H., Arbibe, L., Mounier, J., Gozani, O., Cantley, L., Fry,
M.J., Gaits-Iacovoni, F., Sansonetti, P.J. and Payrastre, B. (2006) PtdIns5P
activates the host cell PI3-kinase/Akt pathway during Shigella ﬂexneri
infection. EMBO J. 25, 1024–1034.
[51] Berger, P., Tersar, K., Ballmer-Hofer, K. and Suter, U. (2009) The CMT4B
disease-causing proteins MTMR2 and MTMR13/SBF2 regulate AKT signaling. J.
Cell Mol. Med. [Epub ahead of print].
[52] Pankiv, S., Alemu, E.A., Brech, A., Bruun, J.A., Lamark, T., Overvatn, A., Bjorkoy,
G. and Johansen, T. (2010) FYCO1 is a Rab7 effector that binds to LC3 and PI3P
to mediate microtubule plus end-directed vesicle transport. J. Cell. Biol. 188,
253–269.
[53] Nandurkar, H.H., Layton, M., Laporte, J., Selan, C., Corcoran, L., Caldwell, K.K.,
Mochizuki, Y., Majerus, P.W. and Mitchell, C.A. (2003) Identiﬁcation of
myotubularin as the lipid phosphatase catalytic subunit associated with the
3-phosphatase adapter protein, 3-PAP. Proc. Natl. Acad. Sci. USA 100, 8660–
8665.
[54] Robinson, F.L. and Dixon, J.E. (2005) The phosphoinositide-3-phosphatase
MTMR2 associates with MTMR13, a membrane-associated pseudophos-
phatase also mutated in type 4B Charcot–Marie–Tooth disease. J. Biol. Chem.
280, 31699–31707.
1318 I. Vergne, V. Deretic / FEBS Letters 584 (2010) 1313–1318[55] Bolino, A., Bolis, A., Previtali, S.C., Dina, G., Bussini, S., Dati, G., Amadio, S., Del
Carro, U., Mruk, D.D., Feltri, M.L., et al. (2004) Disruption of Mtmr2 produces
CMT4B1-like neuropathy with myelin outfolding and impaired
spermatogenesis. J. Cell Biol. 167, 711–721.
[56] Previtali, S.C., Zerega, B., Sherman, D.L., Brophy, P.J., Dina, G., King, R.H., Salih,
M.M., Feltri, L., Quattrini, A., Ravazzolo, R., et al. (2003) Myotubularin-related 2
protein phosphatase and neuroﬁlament light chain protein, both mutated in
CMT neuropathies, interact in peripheral nerve. Hum. Mol. Genet. 12, 1713–
1723.[57] Zhang, J., Wong, C.H., Xia, W., Mruk, D.D., Lee, N.P., Lee, W.M. and Cheng, C.Y.
(2005) Regulation of Sertoli-germ cell adherens junction dynamics via
changes in protein-protein interactions of the N-cadherin-beta-catenin
protein complex which are possibly mediated by c-Src and myotubularin-
related protein 2: an in vivo study using an androgen suppression model.
Endocrinology 146, 1268–1284.
[58] Plant, P.J., Correa, J., Goldenberg, N., Bain, J. and Batt, J. (2009) The inositol
phosphatase MTMR4 is a novel target of the ubiquitin ligase Nedd4. Biochem.
J. 419, 57–63.
